Product Introduction
Bioactivity


英文名: Nepicastat

描述: Nepicastat (SYN117) 是一种选择性的，有效的，口服的多巴胺 β 羟化酶抑制剂，可穿过血脑屏障(BBB)。Nepicastat (SYN117) 对牛和人多巴胺 β 羟化酶产生浓度依赖性抑制作用，IC50值分别为8.5 nM 和 9 nM。

体内活性: Nepicastat (3-100 mg/kg; p.o.; three consecutive times, 12 hours apart times) produces dose-dependent decreases in noradrenaline content, increases in dopamine content and increases in dopamine/noradrenaline ratio in the artery (mesenteric or renal), left ventricle [3]. Animal Model: 15-16 weeks male spontaneously hypertensive rats (SHRs) [3] Dosage: Oral administration; three consecutive times, 12 hours apart Administration: 3, 10, 30, 100 mg/kg Result: Produced dose-dependent decreases in noradrenaline content, increases in dopamine content and increases in dopamine/noradrenaline ratio in the artery (mesenteric or renal), left ventricle and cerebral cortex.

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year